Therapeutic Potential of a Synbiotic to Improve Mental Health in Subjects With Obesity.

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

December 31, 2027

Conditions
Obese Patients (BMI ≥ 30 kg/m²)AnxietyDepressive Disorder
Interventions
DIETARY_SUPPLEMENT

Synbiotic

The synbiotic supplement contains both tannins (350mg) and probiotic strains (Lactobacillus acidophilus, Lactobacillus casei, y Bifidobacterium lactis 2×10 9 UFC/g each) that have already demonstrated a positive health effect in obesity. Besides, participants will follow a dietary intervention to improve their dietary habits and reduce weight by a registered dietitian.

DIETARY_SUPPLEMENT

Placebo

Subjects will recieve a placebo supplement, contained in an identical capsule form as the synbiotic, along with the same dietary intervention to improve their dietary habits and reduce weight by a registered dietitian.

Trial Locations (1)

46020

RECRUITING

FISABIO, Valencia

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Celia Bañuls

OTHER